Use of Immunosuppressants/Immunomodulators in Autoimmune/Inflammatory Dermatologic Diseases during COVID-19 Pandemic—General Recommendation Based on Available Evidence

Detalles Bibliográficos
Autores principales: De, Dipankar, Pandhi, Deepika
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2020
Materias:
IADVL COVID-19 Symposium
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7413441/
https://www.ncbi.nlm.nih.gov/pubmed/32832437
http://dx.doi.org/10.4103/idoj.IDOJ_414_20

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7413441/
https://www.ncbi.nlm.nih.gov/pubmed/32832437
http://dx.doi.org/10.4103/idoj.IDOJ_414_20

Ejemplares similares